Search - tctmd.com

Displaying 681 - 700 of 945

Sort: Relevancy | Date

News Daily News

CHOICE at 1 Year: Sapien, CoreValve Yield Similar Clinical Outcomes

August 11, 2015

News Daily News

肺动脉高压磨损可预测TAVR结果，可以帮助选择潜在适合者

Yael L. Maxwell

August 05, 2015

News Daily News

Pulmonary Hypertension Type Predicts TAVR Outcome, Could Help Select Candidates

Yael L. Maxwell

August 05, 2015

News Daily News

El Tipo de Hipertensión Pulmonar Predice el Resultado TAVR y Podría Ayudar a Seleccionar los Candidatos

Yael L. Maxwell

August 05, 2015

Presentation

Effect of Pulmonary Hypertension Hemodynamic Presentation on Clinical Outcomes in Pts With Severe Symptomatic Aortic Stenosis Undergoing TAVR

Presenter: CJ. O'Sullivan

August 04, 2015

News Industry News

First Aortic Valve Procedure With Newly Approved Device Performed at NYU Langone

July 29, 2015

News Industry News

Boston Scientific Announces CE Mark And FDA Clearance For Safari2 ™ Pre-Shaped Guidewire

July 22, 2015

News Daily News

MVARC Document Offers Template for Mitral Valve Therapeutics Research

Todd Neale

July 16, 2015

News Daily News

Survival Benefit of CoreValve in High-Risk Patients Persists at 2 Years

July 07, 2015

News Daily News

El Beneficio sobre la Supervivencia de CoreValve en Pacientes de Alto Riesgo se Mantiene a los 2 Años

July 07, 2015

News Daily News

CoreValve在高风险患者中的生存益处到2年时依然持续存在

July 07, 2015

News Daily News

CTOs Relatively Frequent in Patients Without Previously Known CAD

Nicole Lou

June 30, 2015

News Daily News

FDA Approves 2 New TAVR Systems for High-Risk, Inoperable Patients

Yael L. Maxwell

June 24, 2015

News Industry News

Medtronic Announces FDA Approval for New TAVR System, Introduces First and Only Recapturable Heart Valve in U.S.

June 23, 2015

News Industry News

Edwards Receives FDA Approval For SAPIEN 3 Transcatheter Heart Valve

June 17, 2015

News Daily News

LV Flow After TAVR Predicts Late Mortality

June 11, 2015

News Industry News

St. Jude Medical Receives FDA Approval to Resume U.S. Evaluation of the Portico System

June 03, 2015

News Daily News

Belgian Registry Reports Similar 3-Year Survival for Sapien, CoreValve in Transfemoral TAVR

Yael L. Maxwell

June 03, 2015

Advertisement

CHOICE at 1 Year: Sapien, CoreValve Yield Similar Clinical Outcomes

肺动脉高压磨损可预测TAVR结果，可以帮助选择潜在适合者

Pulmonary Hypertension Type Predicts TAVR Outcome, Could Help Select Candidates

El Tipo de Hipertensión Pulmonar Predice el Resultado TAVR y Podría Ayudar a Seleccionar los Candidatos

Effect of Pulmonary Hypertension Hemodynamic Presentation on Clinical Outcomes in Pts With Severe Symptomatic Aortic Stenosis Undergoing TAVR

First Aortic Valve Procedure With Newly Approved Device Performed at NYU Langone

Boston Scientific Announces CE Mark And FDA Clearance For Safari2 ™ Pre-Shaped Guidewire

MVARC Document Offers Template for Mitral Valve Therapeutics Research

Survival Benefit of CoreValve in High-Risk Patients Persists at 2 Years

El Beneficio sobre la Supervivencia de CoreValve en Pacientes de Alto Riesgo se Mantiene a los 2 Años

CoreValve在高风险患者中的生存益处到2年时依然持续存在

CTOs Relatively Frequent in Patients Without Previously Known CAD

FDA Approves 2 New TAVR Systems for High-Risk, Inoperable Patients

Medtronic Announces FDA Approval for New TAVR System, Introduces First and Only Recapturable Heart Valve in U.S.

Edwards Receives FDA Approval For SAPIEN 3 Transcatheter Heart Valve

LV Flow After TAVR Predicts Late Mortality

St. Jude Medical Receives FDA Approval to Resume U.S. Evaluation of the Portico System

Belgian Registry Reports Similar 3-Year Survival for Sapien, CoreValve in Transfemoral TAVR

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content